Methylprednisolone plus Chlorambucil as Compared with Methylprednisolone Alone for the Treatment of Idiopathic Membranous Nephropathy

New England Journal of Medicine

Volumn 327, Issue 9, 1992, Pages 599-603

  Ponticelli, Claudio ^a   Zucchelli, Pietro ^b   Passerini, Patrizia ^a   Cesana, Bruno ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Ospedale M Malpighi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; GASTROINTESTINAL TOXICITY; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 0026687712     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199208273270904     Document Type: Article

References (32)

1. Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 1984; 22: 61–7.
2. MacTier R, Boulton-Jones JM, Payton CD, McLay A. The natural history of membranous nephropathy in the West of Scotland. Q J Med 1986; 60: 793–802.
3. Zucchelli P, Ponticelli C, Cagnoli L, Passerini P. Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome. Nephrol Dial Transplant 1987; 2: 73–8.
4. Donadio JV Jr, Torres VE, Velosa JA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988; 33: 708–15.
5. Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989; 320: 210–5.
6. Cameron JS, Healy MJR, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Q J Med 1990; 74: 1313–56.
7. Hopper J Jr. Prednisone in the treatment of idiopathic membranous nephropathy. N Engl J Med 1989; 321: 260–1.
8. Tiller DJ, Clarkson AR, Mathew T, et al. A prospective randomized trial in the use of cyclophosphamide, dipyridamole and warfarin in membranous and mesangiocapillary glomerulonephritis. In: Zurukzoglu W, Papadimitriou M, Pyrpasopoulos M, Sion M, Zamboulis C, eds. Proceedings of the Eighth International Congress of Nephrology: advances in basic and clinical nephrology, Athens, Greece, June 7–12, 1981. Basel, Switzerland: S. Karger, 1981:345–51.
9. Lagrue G, Bernard D, Bariety J, Druet P, Guenel J. Traitement par le chlorambucil et l'azathioprine dans les glomérulonéphrites primitives: résultats d'une étude “contrôlée.” J Urol Néphrol 1975; 81: 655–72.
10. Suki WN, Chavez A. Membranous nephropathy: response to steroids and immunosuppression. Am J Nephrol 1981; 1: 11–6.
11. West ML, Jindal KK, Bear RA, Goldstein MB. A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. Kidney Int 1987; 32: 579–84.
12. Ponticelli C, Zucchelli P, Imbasciati E, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1984; 310: 946–50.
13. Ponticelli C, Zucchelli P, Passerini P, et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320: 8–13.
14. Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med 1976; 295: 741–6.
15. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford, England: Blackwell Scientific, 1987.
16. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
18. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203–23.
19. Kirk RE. Experimental design: procedures for the behavioral sciences. 2nd ed. Monterey, Calif.: Brooks/Cole, 1982.
20. Geisser S, Greenhouse SW. An extension of Box's results on the use of the F distribution in multivariate analysis. Ann Math Stat 1958; 29: 885–91.
21. Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 1988; 34: 382–8.
22. Ramzy MH, Cameron JS, Turner DR, Neild GH, Ogg CS, Hicks J. The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 1981; 16: 13–9.
23. Abe S, Amagasaki Y, Iyori S, Konishi K, Kato E, Sakaguchi H. Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. Am J Nephrol 1989; 9: 30–7.
24. Wehrmann M, Bohle A, Bogenschutz O, et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis: an analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989; 31: 67–76.
25. Ponticelli C, Passerini P. Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome. Nephrol Dial Transplant 1991; 6: 381–8.
26. Cadman EC, Durivage HJ. Cancer chemotherapy. In: Wilson JD, Braunwald E, Isselbacher KJ, et al., eds. Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill, 1991:1587–99.
27. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int 1986; 30: 465–73.
28. Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11: 297–306.
29. Williams PS, Bone JM. Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1989; 4: 181–6.
30. Bruns FJ, Adler S, Fraley DS, Segel DP. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 1991; 114: 725–30.
31. Mathieson PW, Turner AN, Maidment CGH, Evans DJ, Rees AJ. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet 1988; 2: 869–72.
32. Coggins CH. Is idiopathic membranous nephropathy a treatable disease? In: Davison AM, Briggs JD, Green R, et al., eds. Nephrology. London: Baillière Tindall, 1988:695–700.